Trial · NCT04447469
Results by group36
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 36
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Cohort 1, Phase 2: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29 | Phase 2: 10 mg/kg (Cohort 1) | 85.7 | 95% Confidence Interval 69.7 to 95.2 | percentage of participants | |
| Cohort 1, Phase 2: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29 | Phase 2: 6 mg/kg (Cohort 1) | 87.5 | 95% Confidence Interval 73.2 to 95.8 | percentage of participants | |
| Cohort 1, Phase 2: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29 | Phase 2: Placebo (Cohort 1) | 74.4 | 95% Confidence Interval 57.9 to 87.0 | percentage of participants | |
| Cohort 1, Phase 3: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29 | Phase 3: 10 mg/kg (Cohort 1) | 84.3 | 95% Confidence Interval 78.5 to 89.1 | percentage of participants | |
| Cohort 1, Phase 3: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29 | Phase 3: 6 mg/kg (Cohort 1) | 82.8 | 95% Confidence Interval 76.7 to 87.9 | percentage of participants | |
| Cohort 1, Phase 3: Percentage of Participants Alive and Free of Mechanical Ventilation at Day 29 | Phase 3: Placebo (Cohort 1) | 81.3 | 95% Confidence Interval 75.0 to 86.5 | percentage of participants | |
| Cohort 2, Phase 2: Percentage of Participants Who Died by Day 29 | Phase 2: 10 mg/kg (Cohort 2) | 46.7 | 95% Confidence Interval 21.3 to 73.4 | percentage of participants | |
| Cohort 2, Phase 2: Percentage of Participants Who Died by Day 29 | Phase 2: 6 mg/kg (Cohort 2) | 53.3 | 95% Confidence Interval 26.6 to 78.7 | percentage of participants | |
| Cohort 2, Phase 2: Percentage of Participants Who Died by Day 29 | Phase 2: Placebo (Cohort 2) | 47.1 | 95% Confidence Interval 23.0 to 72.2 | percentage of participants | |
| Cohort 2, Phase 3: Percentage of Participants Who Died by Day 29 | Phase 3: 10 mg/kg (Cohort 2) | 40.0 | 95% Confidence Interval 19.1 to 63.9 | percentage of participants | |
| Cohort 2, Phase 3: Percentage of Participants Who Died by Day 29 | Phase 3: 6 mg/kg (Cohort 2) | 27.3 | 95% Confidence Interval 10.7 to 50.2 | percentage of participants | |
| Cohort 2, Phase 3: Percentage of Participants Who Died by Day 29 | Phase 3: Placebo (Cohort 2) | 55.0 | 95% Confidence Interval 31.5 to 76.9 | percentage of participants | |
| Cohort 1, Phase 2: Time to 2-point Clinical Improvement by Day 29 | Phase 2: 10 mg/kg (Cohort 1) | 8.0 | 80% Confidence Interval 6.0 to 8.0 | days | |
| Cohort 1, Phase 2: Time to 2-point Clinical Improvement by Day 29 | Phase 2: 6 mg/kg (Cohort 1) | 7.0 | 80% Confidence Interval 7.0 to 8.0 | days | |
| Cohort 1, Phase 2: Time to 2-point Clinical Improvement by Day 29 | Phase 2: Placebo (Cohort 1) | 11.0 | 80% Confidence Interval 6.0 to 14.0 | days | |
| Phase 2, Cohort 1: Time to Return to Room Air or Discharge by Day 29 | Phase 2: 10 mg/kg (Cohort 1) | 7.0 | 80% Confidence Interval 6.0 to 8.0 | days | |
| Phase 2, Cohort 1: Time to Return to Room Air or Discharge by Day 29 | Phase 2: 6 mg/kg (Cohort 1) | 7.0 | 80% Confidence Interval 6.0 to 7.0 | days | |
| Phase 2, Cohort 1: Time to Return to Room Air or Discharge by Day 29 | Phase 2: Placebo (Cohort 1) | 9.0 | 80% Confidence Interval 6.0 to 13.0 | days | |
| Phase 2, Cohort 1: Percentage of Participants Who Die by Day 29 | Phase 2: 10 mg/kg (Cohort 1) | 5.7 | 95% Confidence Interval 0.7 to 19.2 | percentage of participants | |
| Phase 2, Cohort 1: Percentage of Participants Who Die by Day 29 | Phase 2: 6 mg/kg (Cohort 1) | 10.0 | 95% Confidence Interval 2.8 to 23.7 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04447469/results